Campuses: Home button


Hepatology Program

Florida Hospital Orlando opened its Hepatology Program in March 2007 with the singular goal of offering an internationally recognized program dedicated to the treatment of and research into liver disease. Since then, our program has expanded significantly. Today we are overseeing the care of thousands of our neighbors, as well as patients from around the country and abroad, who are battling viral hepatitis, alcohol-related conditions and other types of liver disease.

These conditions are more common than many of us think. Research indicates that up to a third of the world’s population has been infected with the hepatitis B virus at some point in their lives, and as many as 350 million individuals are persistent carriers. In fact, four out of five liver cancers can be linked to either the hepatitis B or hepatitis C virus.

Our highly skilled and experienced experts provide a full spectrum of services for patients with liver disease, as well as those with pancreatic, gallbladder and biliary tree disease. It is critically important for patients with these conditions to find a facility that provides comprehensive services as well as access to a team of specialists—facilities like Florida Hospital Orlando’s Hepatology Program. The myriad complex conditions and disorders that we treat include:

  • Abnormal liver tests
  • Viral Hepatitis A, B, C, D, E
  • Autoimmune liver disease
  • Autoimmune hepatitis
  • Primary biliary cirrhosis
  • Primary sclerosing cholangitis
  • Overlap syndromes
  • Drug-induced liver injury
  • Liver tumors (malignant and benign)
  • Ascites, esophageal and gastric varices and portal hypertension
  • Hepatic encephalopathy (confusion induced by liver disease)
  • Liver biopsies (ultrasound-guided and laparoscopic)
  • Abdominal paracentesis
  • Pre- and post-transplant services

At the Florida Hospital Orlando Hepatology Program, we’re focused not just on the diagnosis and treatment of liver disease, but also on research into improving the outcomes of our patients. In 2008, for instance, we initiated Phase 2 trials for hepatitis C patients—both those who have not had previous treatment for their illness and those for whom conventional therapies didn’t work. In addition, we have participated in clinical trials that test the efficacy of new medicines for patients with advanced-stage liver cancer. We have also partnered with the University of Central Florida College of Medicine, where we formulated the curriculum for students in the study of liver diseases.

From education to treatment to cutting-edge research, Florida Hospital Orlando strives to offer our liver-disease patients new hope, all in the compassionate, patient-centered environment on which Florida Hospital has staked its reputation for more than a century.